Given that some EV-based proteins were significantly associated with serum PSA levels and that all of our patients had bone-predominant metastatic disease, we further investigated whether the number of bone lesions correlated with the expression of specific EV proteins (Figure 4). The gene discussed is KLK3; the disease is metastatic neoplasm.